Your browser doesn't support javascript.
loading
Psychological impact over time of women with pregnancy loss due to gestational trophoblastic disease compared with miscarriage.
Blok, Laura; Eysbouts, Yalcke; Lok, Christianne A R; Coppus, S F P J; Sweep, Fred C G J; Ottevanger, Petronella.
Afiliación
  • Blok L; Department of Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands laura.j.blok@radboudumc.nl.
  • Eysbouts Y; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
  • Lok CAR; Department of Obstetrics and Gynaecology, Radboudumc, Nijmegen, The Netherlands.
  • Coppus SFPJ; Department of Gynaecologic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sweep FCGJ; Department of Obstetrics and Gynaecology, Maxima Medical Centre, Veldhoven, The Netherlands.
  • Ottevanger P; Department of Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands.
Int J Gynecol Cancer ; 33(12): 1882-1889, 2023 Dec 04.
Article en En | MEDLINE | ID: mdl-37723103
ABSTRACT

OBJECTIVES:

Pregnancy loss, occurring after miscarriage or after gestational trophoblastic disease, has a psychological impact. Besides pregnancy loss, women diagnosed with gestational trophoblastic disease have to deal with a prolonged period of follow-up and potential advice to postpone a future pregnancy. We studied the severity and course of the psychological impact after gestational trophoblastic disease and miscarriage, to identify whether women with gestational trophoblastic disease need different psychological care.

METHODS:

A prospective multicenter study using online questionnaires was performed. Women diagnosed with gestational trophoblastic disease or miscarriage received the following questionnaires directly after diagnosis, and after 6, 6, and 12 months a self-report questionnaire, the Hospital Anxiety and Depression Scale (HADS), the Impact of Event Scale, and the Reproductive Concerns Scale.

RESULTS:

74 women with gestational trophoblastic disease and 76 women with miscarriage were included. At baseline, the proportion of women scoring above the cut-off level for the anxiety subscale of the HADS and for the Impact of Event Scale was significantly higher for women with gestational trophoblastic disease than for women after miscarriage (43.2% vs 28.9%, p=0.02 and 87.8% vs 78.9%, p=0.03, respectively). During follow-up, the differences between both groups vanished and only the Impact of Event Scale after 12 months remained significantly different between women with gestational trophoblastic disease and women after miscarriage (62.7% vs 37.3%, p=0.005). All outcomes, except the Reproductive Concerns Scale, showed a significant decline. However, in women who scored above the cut-off level on the HADS-total or Impact of Event Scale at baseline, and women with psychological or psychiatric history, significant higher scores persisted.

CONCLUSION:

Although women with gestational trophoblastic disease at baseline had more anxiety and distress than women after miscarriage, no significant differences were seen using the HADS-total after 12 months. Using the HADS or Impact of Event Scale directly after pregnancy loss is helpful to identify women at risk of remaining psychological symptoms to provide them with extra psychological support.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Aborto Espontáneo / Enfermedad Trofoblástica Gestacional Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Asunto principal: Aborto Espontáneo / Enfermedad Trofoblástica Gestacional Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos